SOURCE: Nobles Medical Technologies II

Nobles Medical Technologies II

December 21, 2015 15:04 ET

Nobles Medical Technologies II Board Strengthened by Union Capital Group SA's Antoine Felicelli

European COO Brings Significant Financial Expertise to NMT II

LOS ANGELES, CA--(Marketwired - Dec 21, 2015) - Nobles Medical Technologies II announced today the election of Antoine Felicelli, Chief Operating Officer of Union Capital Group SA in Geneva, to its Board of Directors. The election took place at a stockholders meeting held in November, 2015. Prior to his election, Mr. Felicelli had been appointed to the Board in July of 2015 to fill an existing vacancy. Mr. Felicelli joins the board lending his years of knowledge and expertise in finance and corporate governance to Nobles Medical Technologies II. 

Mr. Felicelli has served as the CFO, COO, and a Board Member of Union Capital Group SA since 2012. Prior to that time, Mr. Felicelli was the Managing Director of Union Investment Real Estate France, the French subsidiary of the Hamburg-based real estate asset manager, where he was responsible for the management of an EUR 3 billion French portfolio. He earned a bachelor's degree in Business Administration from ESSEC Business School. Mr. Felicelli is 33 years of age.

Immediately after his election, Mr. Felicelli commented, "I am really delighted to join the Nobles Medical Technologies II Board of Directors, and to be able to bring additional skills to the company. I am convinced that the technologies developed by Nobles Medical Technologies II for PFO closure and others to come will be very successful, and bring tremendous progress in the field of interventional cardiology."

NMT II held a stockholders meeting in November to elect the members of its Board of Directors. The stockholders elected Prof. Anthony Nobles, Benjamin Brosch, Antoine Felicelli, and Richard Babcock to serve on the Board.

Professor Anthony Nobles, CEO and Chairman of the Board of Nobles Medical Technologies II, commented, "Working with Antoine during the past several years, first as an investor representative and then a member of SCS Biomedical -- a significant investor in Nobles Medical Technologies II -- I have developed a great deal of respect for Antoine and his strong financial market knowledge."

About Nobles Medical Technology II
Nobles Medical Technology II, Inc.
was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the PFO, ASD-closure, and vascular-suturing marketplace. The company does business under the name of Nobles Medical II (NMT II). Initial efforts of the company are focused on the innovative suture-based PFO closure system for closing the Patent Foramen Ovale (PFO), a tunnel between the right and left atria of the heart.

The NobleStitch™ is approved for PFO Closure and Cardiovascular suturing in the European Union. The NobleStitch™ EL is FDA cleared for vascular suturing in the United States. NobleStitch™ EL is distributed worldwide by HeartStitch®, Inc. (HeartStitch® is a registered trademark of HeartStitch, Inc.).

For more on Nobles Medical Technologies II visit www.NoblesMedicalTechnology.com.

Contact Information

  • For more information, please contact:

    USA
    Dru Dobbs
    P. +1 714 427 6348
    F. +1 714 427 6343
    ddobbs@nmt2.net